3-10213485-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001570.4(IRAK2):āc.725C>Gā(p.Thr242Arg) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000257 in 1,613,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 18/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001570.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152164Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000135 AC: 34AN: 251468Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135914
GnomAD4 exome AF: 0.000272 AC: 398AN: 1461682Hom.: 0 Cov.: 31 AF XY: 0.000265 AC XY: 193AN XY: 727164
GnomAD4 genome AF: 0.000105 AC: 16AN: 152164Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2022 | The c.725C>G (p.T242R) alteration is located in exon 6 (coding exon 6) of the IRAK2 gene. This alteration results from a C to G substitution at nucleotide position 725, causing the threonine (T) at amino acid position 242 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at